口咽癌患者经口机器人手术后急性味觉功能障碍
本研究比较口咽癌患者接受经口机器人手术(TORS)后与健康对照者的味觉变化。69名参与者接受心理物理味觉测试。随访时33例TORS患者中14例(42%)出现新发味觉障碍,对照者无1例出现。肿瘤同侧味觉识别在患者中下降11.3%,对照者仅变化0.8%。
要点
- TORS术后患者报告味觉变化常见,33例中14例(42%)新发味觉障碍。
- 肿瘤同侧味觉识别评分患者下降11.3%,对照者变化0.8%,组间差异12.2%。
- 悬吊时间与味觉症状或心理物理变化无关。
核心结论
- TORS术后患者报告的味觉变化常见。
- 与健康对照者相比,TORS患者肿瘤同侧味觉识别下降。
- 悬吊时间和舌咽神经损伤不太可能导致症状性味觉障碍。
- 需要进一步研究TORS相关味觉障碍的病因和长期症状负担,以助于口咽癌患者的管理。
研究设计与样本
- 非随机对照队列研究(证据等级3)。
- 招募接受TORS的口咽癌患者和健康对照者。
- 参与者在基线和术后2周(患者)或随访时(对照者)接受后外侧和全口味觉心理物理测试(识别、强度、愉悦度)。
- 外科医生根据神经的识别和牺牲报告悬吊时间和舌咽神经损伤(GNI)。
- 每次访视完成味觉症状的临床总体印象(CGI),「我的味觉困扰我」采用5分制(从不[1]至总是[5])。
主要发现
- 69名参与者中,多数(肿瘤组33/37,对照组31/32)基线味觉正常(CGI<3)。
- 随访时33例TORS患者中14例(42%)出现新发味觉障碍,对照者无1例出现。
- 吸烟者中味觉恶化7/9,非吸烟者中19/60,差异46%(95%CI 16%-76%)。
- 无GNI患者术后幻味6/22,有GNI患者0/15,差异27%(95%CI 9-45%)。
- 肿瘤同侧味觉识别在患者中下降11.3%,对照者变化0.8%,差异12.2%(95%CI 5.0-19.3%)。
关键数值与推荐
- 味觉障碍定义为CGI为3(有时)或更差。
- 味觉恶化定义为随访时CGI增加≥1分。
- 肿瘤同侧味觉识别:患者下降11.3% vs 对照者变化0.8%,差异12.2%(95%CI 5.0-19.3%)。
- 新发味觉障碍:TORS患者14/33(42%),对照者无1例出现。
- 吸烟者味觉恶化7/9 vs 非吸烟者19/60,差异46%(95%CI 16%-76%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究TORS相关味觉障碍的病因和长期症状负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare taste changes after transoral robotic surgery (TORS) to taste changes in healthy controls. METHODS: Oropharyngeal cancer patients receiving TORS and healthy controls were recruited. Participants underwent posterolateral and whole-mouth psychophysical taste testing (identification, intensity, and hedonics) at baseline and at 2 weeks postoperatively (patients) or follow-up (controls). Surgeons reported suspension time and glossopharyngeal nerve injury (GNI) based on the identification and sacrifice of the nerve. A Clinical Global Impression (CGI) of taste symptoms was completed at each session ("My sense of taste bothers me" on a 5-point scale from Never [1] to Always [5]). A taste disorder (TD) was a CGI of 3 (Sometimes) or worse. Within-subject changes in CGI and psychophysical scores were computed. "Worsened taste" was a CGI increase by ≥1 point at follow-up. RESULTS: Of 69 participants, most (33/37 tumor, 31/32 controls) had normal baseline taste (CGI < 3). 14/33 (42%) TORS patients and no controls developed new TDs at follow-up. More smokers (7/9) had worsened taste than nonsmokers (19/60, difference = 46% [95% CI 16%-76%]). More patients without GNI (6/22) than with GNI (0/15) had postoperative phantogeusia (difference = 27% [95% CI 9-45%]). Tumor-ipsilateral taste identification (TI) decreased more in patients (-11.3%) than controls (0.8%, difference = 12.2% [95% CI 5.0-19.3%]). Suspension time was not associated with worsened taste symptoms or psychophysical changes. CONCLUSIONS: Patient-reported taste changes after TORS are frequent. Compared to healthy controls, TORS patients have decreased tumor-ipsilateral TI. Suspension time and GNI are unlikely to cause symptomatic TDs. Further investigations of the etiology and long-term symptom burden of TORS-associated TDs will aid in the management of oropharyngeal cancer patients. LEVEL OF EVIDENCE: 3 (non-randomized controlled cohort study) Laryngoscope, 133:3520-3528, 2023.
引用
- Tharakan T, Piccirillo JF, Miller B, et al. Acute Taste Dysfunction in Oropharyngeal Cancer Patients after Transoral Robotic Surgery. Laryngoscope. 2023. PMID: 37551882. doi:10.1002/lary.30939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。